Tue 6/25/2019 16:04 ET
DJIA26548.22177.870.67%TELCO173.050.740.43%GOLD1427.058.850.62%Shanghai2982.0725.940.87%
S&P 5002917.7227.430.94%BANKS431.071.980.46%OIL57.840.060.10%BITCOIN11363.95337.512.97%
NASDAQ7884.72119.061.51%PHARM592.517.881.33%US/EU1.140.000.00%Futures2923.8828.070.96%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Wall Street Pit    Stock Due Diligence for All

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search
  
From: SunTzu772 (Rep: 1132)Date: 06/11/2019 09:40
Forum: Wall Street Pit - Msg #2789633Thread #674085594 (Rec: 8)
73.9% funds/insiders..13D's tell the story when this float is captured.

https://www.sec.gov/Archives/edgar/data/1697805/000121390019009702/sc13d052919xu_xynomic.htm

https://www.sec.gov/Archives/edgar/data/1697805/000121390019009783/sc13d0519wu_xynomicpharma.htm

https://www.sec.gov/Archives/edgar/data/1697805/000121390019009804/sc13d0519qian_xynomicpharma.htm

"Total payments of Xynomic associated with the licensing agreement, including an upfront payment, regulatory milestone payments and potential royalties, will be up to $800 million."

Xynomic Pharma Acquires Global Exclusive Rights to Phase 2 Ready mTORC1/2 Inhibitor from Boehringer Ingelheim

https://www.prnewswire.com/news-releases/xynomic-pharma-acquires-global-exclusive-rights-to-phase-2-ready-mtorc12-inhibitor-from-boehringer-ingelheim-300769632.html

https://www.globenewswire.com/news-release/2019/06/06/1865543/0/en/Xynomic-Dosed-First-Patient-in-Phase-1-2-Lymphoma-Trial.html



------------------- "Opportunities multiply as they are seized" -- Sun Tzu circa 500 B.C. -------------------

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser SunTzu772: Reward | Watch | Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.